Immucell Corp (ICCC) Reports Q2 EPS of $0.00
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ImmuCell Announces Second Quarter 2016 Financial Results
August 11, 2016 4:05 PM EDTPORTLAND, ME -- (Marketwired) -- 08/11/16 -- ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial results for its second quarter ended June 30, 2016.
2016 Second Quarter Financial Overview:
Total sales of $2.4 million increased by 21%, or $415,000, during the second quarter of 2016 compared to the second quarter of 2015;Total sales of $5.4 million increased by 6%, or $300,000, during the six-month period ended June 30, 2016... More